Agilent Technologies Inc (A):企業の財務・戦略的SWOT分析

◆英語タイトル:Agilent Technologies Inc (A) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME3859FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:70
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Agilent Technologies Inc (A) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Agilent Technologies Inc (Agilent) is a provider of instruments, reagents, software, services and consumables for comprehensive laboratory workflow. Its product portfolio comprises liquid chromatography systems and components, gas chromatography systems and components, microarray solutions, clinical and diagnostic testing, and automation systems, among others. The company serves biotechnology, pharmaceutical, contract research organizations (CROs) and contract manufacturing organizations (CMOs), chemical and energy, environmental and forensics, food and other industries. Agilent markets products through direct sales force, distributors, manufacturers’ representatives, resellers and e-commerce. It has research and development and manufacturing facilities in the US, the UK, Denmark, Germany, Italy, Japan, Malaysia, China, Singapore and Australia. Agilent is headquartered in Santa Clara, California, the US.

Agilent Technologies Inc Key Recent Developments

Mar 30,2021: Agilent awards Octagon Therapeutics with a Golden Ticket at LabCentral
Mar 09,2021: Dr. Katharine Knobil Named Agilent’s First Chief Medical Officer
Mar 03,2021: Agilent Technologies agrees to acquire Resolution Bioscience for $695m
Feb 17,2021: Agilent reports first-quarter fiscal year 2021 financial results
Jan 26,2021: Agilent to Webcast First-Quarter Fiscal Year 2021 Financial Results Presentation

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Agilent Technologies Inc – Key Facts
Agilent Technologies Inc – Key Employees
Agilent Technologies Inc – Key Employee Biographies
Agilent Technologies Inc – Major Products and Services
Agilent Technologies Inc – History
Agilent Technologies Inc – Company Statement
Agilent Technologies Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Agilent Technologies Inc – Business Description
Business Segment: Agilent CrossLab
Overview
Performance
Key Stats
Business Segment: Diagnostics and Genomics
Overview
Performance
Key Stats
Business Segment: Life Sciences and Applied Markets
Overview
Performance
Key Stats
Geographical Segment: China
Performance
Geographical Segment: Rest of the World
Target Markets
Performance
Geographical Segment: United States
Performance
R&D Overview
Agilent Technologies Inc – Corporate Strategy
Agilent Technologies Inc – SWOT Analysis
SWOT Analysis – Overview
Agilent Technologies Inc – Strengths
Agilent Technologies Inc – Weaknesses
Agilent Technologies Inc – Opportunities
Agilent Technologies Inc – Threats
Agilent Technologies Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Agilent Technologies Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Agilent Technologies Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Agilent Technologies Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 30, 2021: Agilent awards Octagon Therapeutics with a Golden Ticket at LabCentral
Mar 09, 2021: Dr. Katharine Knobil Named Agilent’s First Chief Medical Officer
Feb 17, 2021: Agilent reports first-quarter fiscal year 2021 financial results
Jan 26, 2021: Agilent to Webcast First-Quarter Fiscal Year 2021 Financial Results Presentation
Jan 25, 2021: Agilent announces enhanced mass spectrometry and automation software solutions to support regulatory compliance guidelines
Jan 15, 2021: Agilent names Allison Ballmer Senior Vice President of Strategy and Corporate Development
Dec 14, 2020: Agilent receives multiple innovation awards
Dec 07, 2020: Agilent presents thought leader award to IIT Delhi scientist professor Anurag Rathore
Dec 03, 2020: Agilent announces Alissa Interpret selected by North West Genomic Laboratory Hub for Clinical Genomic Analysis
Dec 02, 2020: Agilent announces new, innovative 7850 ICP-MS system
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Agilent Technologies Inc, Key Facts
Agilent Technologies Inc, Key Employees
Agilent Technologies Inc, Key Employee Biographies
Agilent Technologies Inc, Major Products and Services
Agilent Technologies Inc, History
Agilent Technologies Inc, Subsidiaries
Agilent Technologies Inc, Key Competitors
Agilent Technologies Inc, Ratios based on current share price
Agilent Technologies Inc, Annual Ratios
Agilent Technologies Inc, Annual Ratios (Cont...1)
Agilent Technologies Inc, Annual Ratios (Cont...2)
Agilent Technologies Inc, Interim Ratios
Agilent Technologies Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Agilent Technologies Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Agilent Technologies Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Agilent Technologies Inc (A):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Egdon Resources Plc (EDR):企業の財務・戦略的SWOT分析
    Summary Egdon Resources Plc (Egdon) is oil and gas company that offers exploration and production services. The company explores and develops petroleum and natural gas assets in East Midlands, North East England, North West England, and Southern England, the UK. Its project site includes Wressle, No …
  • Evoke Pharma Inc (EVOK):製薬・医療:M&Aディール及び事業提携情報
    Summary Evoke Pharma Inc (Evoke Pharma) is a pharmaceutical company that develops drugs to treat gastrointestinal diseases. The company offers Gimoti that provides predictable absorption and symptom relief during a flare regardless of gastric emptying delays and vomiting. It also offers solutions fo …
  • Hangzhou Tigermed Consulting Co Ltd (300347):企業の財務・戦略的SWOT分析
    Summary Hangzhou Tigermed Consulting Co Ltd (Tigermed) is a contract research organization (CRO) that provides clinical trial services. It offers regulatory submission and approval, medical translation and GMP (Good Manufacturing Practice) consulting, medical monitoring, project management, medical …
  • Toyota Industries Corporation (6201):企業の財務・戦略的SWOT分析
    Toyota Industries Corporation (6201) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Entreprise Tunisienne d’Activites Petrolieres:企業の戦略的SWOT分析
    Entreprise Tunisienne d'Activites Petrolieres - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Microchip Technology Inc (MCHP):企業の財務・戦略的SWOT分析
    Microchip Technology Inc (MCHP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Westgold Resources Ltd (WGX):企業の財務・戦略的SWOT分析
    Westgold Resources Ltd (WGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Sunsweet Growers Inc.:企業の戦略・SWOT・財務情報
    Sunsweet Growers Inc. - Strategy, SWOT and Corporate Finance Report Summary Sunsweet Growers Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • UNIQA Romania:企業の戦略・SWOT・財務情報
    UNIQA Romania - Strategy, SWOT and Corporate Finance Report Summary UNIQA Romania - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • MPC Munchmeyer Petersen Capital AG (MPCK):企業の財務・戦略的SWOT分析
    Summary MPC Munchmeyer Petersen Capital AG (MPC), a subsidiary of MPC Munchmeyer Petersen & Co GmbH, is an asset and investment management firm. The firm business segments include infrastructure, real estate and shipping. Its real estate business concentrates on micro living or student housing. Its …
  • SAE Towers Holdings LLC:企業の戦略的SWOT分析
    SAE Towers Holdings LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • juwi AG:企業の戦略的SWOT分析
    juwi AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Biocad:製薬・医療:M&Aディール及び事業提携情報
    Summary Biocad is a biotechnology company that conducts research and development services. The company develops, manufactures and distributes generic pharmaceutical products. It develops products in urology, gynecology, dermatology, oncology, hematology, autoimmune diseases and infectious diseases t …
  • RS Software (India) Limited (RSSOFTWARE):企業の財務・戦略的SWOT分析
    RS Software (India) Limited (RSSOFTWARE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Enterprise Ireland:企業のM&A・事業提携・投資動向
    Enterprise Ireland - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Enterprise Ireland Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • SFJ Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary SFJ Pharmaceuticals Inc (SFJ Pharmaceuticals) is a drug company that provides funding and strategic development expertise services. The company offers management of phase III oncology clinical trials, phase II trials and regulatory approvals. Its services includes clinical operations, busine …
  • Asian American Medical Group Ltd (AJJ):企業の財務・戦略的SWOT分析
    Asian American Medical Group Ltd (AJJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • PT Bank CIMB Niaga Tbk (BNGA):企業の財務・戦略的SWOT分析
    PT Bank CIMB Niaga Tbk (BNGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • System Dynamics International Incorporated:企業の戦略・SWOT・財務情報
    System Dynamics International Incorporated - Strategy, SWOT and Corporate Finance Report Summary System Dynamics International Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • BioLineRx Ltd (BLRX)-医療機器分野:企業M&A・提携分析
    Summary BioLineRx Ltd (BioLineRx) is a clinical stage biopharmaceutical company that focuses on the identification, in-licensing, and development of products to address unmet medical needs. The company’s product pipeline includes BL-8040, a short peptide for multiple cancer and hematological indicat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆